Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Diabetes Care|June 3, 2009
Biphasic insulin aspart 30/70: pharmacokinetics and pharmacodynamics compared with once-daily biphasic human insulin and Basal-bolus therapyTim Heise, Lutz Heinemann, Ulrike Hövelmann, et al.
Clinical Drug Investigation|August 16, 2014
Glucose-lowering effect of insulin degludec is independent of subcutaneous injection regionLeszek Nosek, Hans-Veit Coester, Carsten Roepstorff, et al.
Diabetes Care|November 28, 2002
Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetesAyesh D Perera, Christoph Kapitza, Leszek Nosek, et al.
Journal of Diabetes|January 13, 2015
Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of actionTim Heise, Stefan Korsatko, Leszek Nosek, et al.
Diabetes Technology & Therapeutics|March 2, 2011
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetesRonald J Pettis, Laurence Hirsch, Christoph Kapitza, et al.
Diabetes Care|September 28, 2005
Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lisproKlaus M Rave, Leszek Nosek, Amparo de la Peña, et al.
Clinical Pharmacokinetics|May 30, 2020
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog<sup>®</sup> (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover StudyJennifer Leohr, Mary Anne Dellva, David E Coutant, et al.
Diabetologia|December 26, 2015
Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetesElza Muscelli, Brenno Astiarraga, Elisabetta Barsotti, et al.
Drug Delivery and Translational Research|June 4, 2015
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wearChristopher James Rini, Elaine McVey, Diane Sutter, et al.
Diabetes Technology & Therapeutics|March 2, 2011
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injectionRonald J Pettis, Barry Ginsberg, Laurence Hirsch, et al.
Pageof 3